Boersema M, Rienstra H, van den Heuvel M, van GH, van Luyn MJ, Navis GJ, Popa ER, and Hillebrands JL. (2009). Donor and recipient contribution to transplant vasculopathy in chronic renal transplant dysfunction. Transplantation 88: 1386-92. PubMed


Broekema M, Harmsen MC, Koerts JA, van Kooten TG, Uges DR, Petersen AH, van Luyn MJ, Navis G, and Popa ER. (2009). Ciclosporin does not influence bone marrow-derived cell differentiation to myofibroblasts early after renal ischemia/reperfusion. Am J Nephrol 30: 73-83. PubMed


Koning M, Harmsen MC, van Luyn MJ, and Werker PM. (2009). Current opportunities and challenges in skeletal muscle tissue engineering. J Tissue Eng Regen Med 3: 407-15. PubMed


Krenning G, Dankers PY, Drouven JW, Waanders F, Franssen CF, van Luyn MJ, Harmsen MC, and Popa ER. (2009). Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. Am J Physiol Renal Physiol 296: F1314-F1322. PubMed


Krenning G, Moonen JR, and Harmsen MC. (2009). Pleiotropism of adiponectin: inflammation, neovascularization, and fibrosis. Circ Res 104: 1029-31. PubMed


Krenning G, van Luyn MJ, and Harmsen MC. (2009). Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Mol Med 15: 180-9. PubMed


Krenning G, van der Strate BW, Schipper M, van Seijen XJ, Fernandes BC, van Luyn MJ, and Harmsen MC. (2009). CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med 13: 2521-33. PubMed


van Putten SM, Wubben M, Hennink WE, van Luyn MJ, and Harmsen MC. (2009). The downmodulation of the foreign body reaction by cytomegalovirus encoded interleukin-10. Biomaterials 30: 730-5. PubMed